Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 36.99 M32.86 M35.16 M37 M35.95 M 140.97 M Research & development ————— — Operating income -3.62 M-104.9 M-3.01 M-143.19 M-7 000 -251.11 M Non-Operating Income, Total -5 M-4.42 M-5.42 M-7.39 M-7.99 M -25.23 M Interest expense, net of interest capitalized 3.11 M3.09 M3.08 M4.67 M3.84 M 14.68 M Non-Operating Income, excl. Interest Expenses -4.77 M-4.4 M-5.41 M-7.44 M-7.99 M -25.24 M Unusual income/expense -227 K-26 K-9 00046 K-2 000 9 000 Pretax income -8.62 M-109.33 M-8.43 M-150.58 M-8 M -276.34 M Equity in earnings ————— — Taxes -452 K-1.3 M-1.81 M-2.31 M2.03 M -3.38 M Non-controlling/minority interest -221 K-5.78 M-203 K-8.16 M-94 K -14.24 M After tax other income/expense ————— — Net income before discontinued operations -7.95 M-102.25 M-6.41 M-140.11 M-9.94 M -258.72 M Discontinued operations ————— — Net income -7.95 M-102.25 M-6.41 M-140.11 M-9.94 M -258.72 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -7.95 M-102.25 M-6.41 M-140.11 M-9.94 M -258.72 M Basic earnings per share (Basic EPS) -0.09-1.15-0.1-1.66-0.12 -3.03 Diluted earnings per share (Diluted EPS) -0.09-1.15-0.1-1.66-0.12 -3.03 Average basic shares outstanding 89.01 B88.83 B86.72 B85.56 B82.52 B — Diluted shares outstanding 89.01 B88.83 B86.72 B85.56 B82.52 B — EBITDA 21.99 M-78.8 M23.17 M-41.57 M25.85 M -71.35 M EBIT -3.62 M-104.9 M-3.01 M-143.19 M-7 000 -251.11 M Cost of revenue 18.66 M18.4 M19.93 M20.24 M19.31 M 77.89 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 25.61 M26.11 M26.18 M101.62 M25.86 M 179.76 M